ADMA Biologics (ADMA)
(Delayed Data from NSDQ)
$8.81 USD
+1.88 (27.13%)
Updated May 10, 2024 04:00 PM ET
After-Market: $8.81 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | 0.07 |
EPS Last Quarter | 0.08 |
Last EPS Surprise | 60.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.30 |
Next Year | 0.50 |
EPS (TTM) | 0.11 |
P/E (F1) | 23.36 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 82.15M | 86.25M | 335.70M | 390.25M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 83.00M | 87.00M | 337.00M | 390.50M |
Low Estimate | 81.30M | 85.50M | 334.40M | 390.00M |
Year ago Sales | 60.12M | 67.28M | 258.22M | 335.70M |
Year over Year Growth Est. | 36.64% | 28.20% | 30.01% | 16.25% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.07 | 0.08 | 0.30 | 0.50 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | 0.05 | 0.07 | 0.31 | 0.51 |
High Estimate | 0.07 | 0.08 | 0.32 | 0.51 |
Low Estimate | 0.07 | 0.07 | 0.28 | 0.48 |
Year ago EPS | -0.02 | 0.01 | 0.00 | 0.30 |
Year over Year Growth Est. | 450.00% | 700.00% | NA | 66.11% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.07 | 0.08 | 0.30 | 0.50 |
7 Days Ago | 0.07 | 0.08 | 0.30 | 0.50 |
30 Days Ago | 0.07 | 0.08 | 0.30 | 0.50 |
60 Days Ago | 0.07 | 0.08 | 0.30 | 0.50 |
90 Days Ago | 0.04 | 0.06 | 0.22 | 0.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.07 | 0.08 | 0.30 | 0.50 |
Zacks Consensus Estimate | 0.07 | 0.08 | 0.30 | 0.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.08 | 0.04 | 0.01 | -0.02 | NA |
Estimate | 0.05 | 0.02 | -0.01 | -0.02 | NA |
Difference | 0.03 | 0.02 | 0.02 | 0.00 | 0.02 |
Surprise | 60.00% | 100.00% | 200.00% | 0.00% | 90.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more